HEADER IMMUNE SYSTEM 03-FEB-06 2FX7 TITLE CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH TITLE 2 A 16-RESIDUE PEPTIDE ENCOMPASSING THE 4E10 EPITOPE ON GP41 COMPND MOL_ID: 1; COMPND 2 MOLECULE: FAB 4E10; COMPND 3 CHAIN: L; COMPND 4 FRAGMENT: LIGHT CHAIN; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: FAB 4E10; COMPND 8 CHAIN: H; COMPND 9 FRAGMENT: HEAVY CHAIN; COMPND 10 ENGINEERED: YES; COMPND 11 MOL_ID: 3; COMPND 12 MOLECULE: FRAGMENT OF HIV GLYCOPROTEIN (GP41); COMPND 13 CHAIN: P; COMPND 14 FRAGMENT: PEPTIDE EPITOPE OF 4E10; COMPND 15 ENGINEERED: YES; COMPND 16 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 6 EXPRESSION_SYSTEM_COMMON: CHINESE HAMSTER; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 13 EXPRESSION_SYSTEM_COMMON: CHINESE HAMSTER; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 15 MOL_ID: 3; SOURCE 16 SYNTHETIC: YES; SOURCE 17 OTHER_DETAILS: THIS SEQUENCE INCLUDES A FRAGMENT OF THE HIV ENVELOPE SOURCE 18 PROTEIN GP41 KEYWDS IMMUNOGLOBULIN FOLD, BETA-SANDWICH, ANTIBODY-EPITOPE COMPLEX, IMMUNE KEYWDS 2 SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR R.M.F.CARDOSO,F.M.BRUNEL,S.FERGUSON,D.R.BURTON,P.E.DAWSON,I.A.WILSON REVDAT 7 13-NOV-24 2FX7 1 REMARK REVDAT 6 30-AUG-23 2FX7 1 REMARK REVDAT 5 20-OCT-21 2FX7 1 REMARK SEQADV REVDAT 4 13-JUL-11 2FX7 1 VERSN REVDAT 3 24-FEB-09 2FX7 1 VERSN REVDAT 2 04-SEP-07 2FX7 1 JRNL REVDAT 1 19-DEC-06 2FX7 0 JRNL AUTH R.M.CARDOSO,F.M.BRUNEL,S.FERGUSON,M.ZWICK,D.R.BURTON, JRNL AUTH 2 P.E.DAWSON,I.A.WILSON JRNL TITL STRUCTURAL BASIS OF ENHANCED BINDING OF EXTENDED AND JRNL TITL 2 HELICALLY CONSTRAINED PEPTIDE EPITOPES OF THE BROADLY JRNL TITL 3 NEUTRALIZING HIV-1 ANTIBODY 4E10. JRNL REF J.MOL.BIOL. V. 365 1533 2007 JRNL REFN ISSN 0022-2836 JRNL PMID 17125793 JRNL DOI 10.1016/J.JMB.2006.10.088 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH R.M.F.CARDOSO,M.B.ZWICK,R.L.STANFIELD,R.KUNERT,J.M.BINLEY, REMARK 1 AUTH 2 H.KATINGER,D.R.BURTON,I.A.WILSON REMARK 1 TITL BROADLY NEUTRALIZING ANTI-HIV ANTIBODY 4E10 RECOGNIZES A REMARK 1 TITL 2 HELICAL CONFORMATION OF A HIGHLY CONSERVED FUSION-ASSOCIATED REMARK 1 TITL 3 MOTIF IN GP41 REMARK 1 REF IMMUNITY V. 22 163 2005 REMARK 1 REFN ISSN 1074-7613 REMARK 1 PMID 15723805 REMARK 1 DOI 10.1016/J.IMMUNI.2004.12.011 REMARK 2 REMARK 2 RESOLUTION. 1.76 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.76 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 98.7 REMARK 3 NUMBER OF REFLECTIONS : 53993 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.202 REMARK 3 FREE R VALUE : 0.222 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 2689 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.76 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.77 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2770 REMARK 3 BIN FREE R VALUE : 0.3620 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 32 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3486 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 6 REMARK 3 SOLVENT ATOMS : 337 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 18.10 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 24.60 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.23100 REMARK 3 B22 (A**2) : -0.36400 REMARK 3 B33 (A**2) : -1.86700 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.92100 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.20 REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.005 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : ISOTROPIC REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.363 ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.206 ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : 2.033 ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.019 ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : 0.40 REMARK 3 BSOL : 47.00 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2FX7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 21-FEB-06. REMARK 100 THE DEPOSITION ID IS D_1000036418. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-MAR-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL11-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97945 REMARK 200 MONOCHROMATOR : CURVED CRYSTAL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 53993 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.760 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 200 DATA REDUNDANCY : 3.700 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.06500 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 14.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.76 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.82 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 3.70 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.30200 REMARK 200 <I/SIGMA(I)> FOR SHELL : 5.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1TZG REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.98 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.79 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 26% PEG 8000, 0.2 M SODIUM ACETATE, REMARK 280 0.2 M SODIUM THIOCYANATE, PH 5.6, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 78.97000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 22.32900 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 78.97000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 22.32900 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5000 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 20820 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -34.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: L, H, P REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH P 91 O HOH P 219 2657 0.59 REMARK 500 O HOH P 187 O HOH P 330 2657 0.67 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA L 51 -36.66 69.54 REMARK 500 ALA L 84 -165.28 -168.65 REMARK 500 LYS L 190 -61.18 -103.78 REMARK 500 TRP H 100B 23.71 -141.63 REMARK 500 SER H 130 1.79 -161.18 REMARK 500 ASP H 146 64.01 64.45 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL L 701 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1TZG RELATED DB: PDB REMARK 900 FAB 4E10 BOUND TO A 13-RESIDUE PEPTIDE EPITOPE REMARK 900 RELATED ID: 2FX8 RELATED DB: PDB REMARK 900 FAB 4E10 BOUND TO AN AIB-INDUCED PEPTIDE EPITOPE REMARK 900 RELATED ID: 2FX9 RELATED DB: PDB REMARK 900 FAB 4E10 BOUND TO A THIOETHER-LINKED PEPTIDE EPITOPE REMARK 999 REMARK 999 NO DATABASE REFERENCE IS CURRENTLY AVAILABLE FOR THE LIGHT AND REMARK 999 HEAVY CHAINS (CHAIN L AND H). DBREF 2FX7 P 671 686 UNP P05880 ENV_HV1W2 662 677 DBREF 2FX7 L 1 213 PDB 2FX7 2FX7 1 213 DBREF 2FX7 H 1 228 PDB 2FX7 2FX7 1 228 SEQADV 2FX7 LYS P 684 UNP P05880 ILE 675 ENGINEERED MUTATION SEQADV 2FX7 LYS P 685 UNP P05880 PHE 676 ENGINEERED MUTATION SEQADV 2FX7 LYS P 686 UNP P05880 ILE 677 ENGINEERED MUTATION SEQRES 1 L 214 GLU ILE VAL LEU THR GLN SER PRO GLY THR GLN SER LEU SEQRES 2 L 214 SER PRO GLY GLU ARG ALA THR LEU SER CYS ARG ALA SER SEQRES 3 L 214 GLN SER VAL GLY ASN ASN LYS LEU ALA TRP TYR GLN GLN SEQRES 4 L 214 ARG PRO GLY GLN ALA PRO ARG LEU LEU ILE TYR GLY ALA SEQRES 5 L 214 SER SER ARG PRO SER GLY VAL ALA ASP ARG PHE SER GLY SEQRES 6 L 214 SER GLY SER GLY THR ASP PHE THR LEU THR ILE SER ARG SEQRES 7 L 214 LEU GLU PRO GLU ASP PHE ALA VAL TYR TYR CYS GLN GLN SEQRES 8 L 214 TYR GLY GLN SER LEU SER THR PHE GLY GLN GLY THR LYS SEQRES 9 L 214 VAL GLU VAL LYS ARG THR VAL ALA ALA PRO SER VAL PHE SEQRES 10 L 214 ILE PHE PRO PRO SER ASP GLU GLN LEU LYS SER GLY THR SEQRES 11 L 214 ALA SER VAL VAL CYS LEU LEU ASN ASN PHE TYR PRO ARG SEQRES 12 L 214 GLU ALA LYS VAL GLN TRP LYS VAL ASP ASN ALA LEU GLN SEQRES 13 L 214 SER GLY ASN SER GLN GLU SER VAL THR GLU GLN ASP SER SEQRES 14 L 214 LYS ASP SER THR TYR SER LEU SER SER THR LEU THR LEU SEQRES 15 L 214 SER LYS ALA ASP TYR GLU LYS HIS LYS VAL TYR ALA CYS SEQRES 16 L 214 GLU VAL THR HIS GLN GLY LEU SER SER PRO VAL THR LYS SEQRES 17 L 214 SER PHE ASN ARG GLY GLU SEQRES 1 H 228 GLN VAL GLN LEU VAL GLN SER GLY ALA GLU VAL LYS ARG SEQRES 2 H 228 PRO GLY SER SER VAL THR VAL SER CYS LYS ALA SER GLY SEQRES 3 H 228 GLY SER PHE SER THR TYR ALA LEU SER TRP VAL ARG GLN SEQRES 4 H 228 ALA PRO GLY ARG GLY LEU GLU TRP MET GLY GLY VAL ILE SEQRES 5 H 228 PRO LEU LEU THR ILE THR ASN TYR ALA PRO ARG PHE GLN SEQRES 6 H 228 GLY ARG ILE THR ILE THR ALA ASP ARG SER THR SER THR SEQRES 7 H 228 ALA TYR LEU GLU LEU ASN SER LEU ARG PRO GLU ASP THR SEQRES 8 H 228 ALA VAL TYR TYR CYS ALA ARG GLU GLY THR THR GLY TRP SEQRES 9 H 228 GLY TRP LEU GLY LYS PRO ILE GLY ALA PHE ALA HIS TRP SEQRES 10 H 228 GLY GLN GLY THR LEU VAL THR VAL SER SER ALA SER THR SEQRES 11 H 228 LYS GLY PRO SER VAL PHE PRO LEU ALA PRO SER SER LYS SEQRES 12 H 228 SER THR SER GLY GLY THR ALA ALA LEU GLY CYS LEU VAL SEQRES 13 H 228 LYS ASP TYR PHE PRO GLU PRO VAL THR VAL SER TRP ASN SEQRES 14 H 228 SER GLY ALA LEU THR SER GLY VAL HIS THR PHE PRO ALA SEQRES 15 H 228 VAL LEU GLN SER SER GLY LEU TYR SER LEU SER SER VAL SEQRES 16 H 228 VAL THR VAL PRO SER SER SER LEU GLY THR GLN THR TYR SEQRES 17 H 228 ILE CYS ASN VAL ASN HIS LYS PRO SER ASN THR LYS VAL SEQRES 18 H 228 ASP LYS LYS VAL GLU PRO LYS SEQRES 1 P 16 ASN TRP PHE ASP ILE THR ASN TRP LEU TRP TYR ILE LYS SEQRES 2 P 16 LYS LYS LYS HET GOL L 701 6 HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 4 GOL C3 H8 O3 FORMUL 5 HOH *337(H2 O) HELIX 1 1 VAL L 28 ASN L 31 5 4 HELIX 2 2 GLU L 79 PHE L 83 5 5 HELIX 3 3 SER L 121 SER L 127 1 7 HELIX 4 4 LYS L 183 GLU L 187 1 5 HELIX 5 5 PRO H 61 GLN H 64 5 4 HELIX 6 6 ARG H 83 THR H 87 5 5 HELIX 7 7 SER H 163 ALA H 165 5 3 HELIX 8 8 SER H 196 LEU H 198 5 3 HELIX 9 9 LYS H 213 ASN H 216 5 4 HELIX 10 10 ASN P 671 PHE P 673 5 3 HELIX 11 11 ASP P 674 LYS P 686 1 13 SHEET 1 A 4 LEU L 4 THR L 5 0 SHEET 2 A 4 ALA L 19 ALA L 25 -1 O ARG L 24 N THR L 5 SHEET 3 A 4 ASP L 70 ILE L 75 -1 O LEU L 73 N LEU L 21 SHEET 4 A 4 PHE L 62 SER L 67 -1 N SER L 63 O THR L 74 SHEET 1 B 5 THR L 10 LEU L 13 0 SHEET 2 B 5 THR L 102 VAL L 106 1 O LYS L 103 N GLN L 11 SHEET 3 B 5 VAL L 85 GLN L 90 -1 N TYR L 86 O THR L 102 SHEET 4 B 5 LEU L 33 GLN L 38 -1 N ALA L 34 O GLN L 89 SHEET 5 B 5 ARG L 45 ILE L 48 -1 O LEU L 47 N TRP L 35 SHEET 1 C 4 THR L 10 LEU L 13 0 SHEET 2 C 4 THR L 102 VAL L 106 1 O LYS L 103 N GLN L 11 SHEET 3 C 4 VAL L 85 GLN L 90 -1 N TYR L 86 O THR L 102 SHEET 4 C 4 THR L 97 PHE L 98 -1 O THR L 97 N GLN L 90 SHEET 1 D 4 SER L 114 PHE L 118 0 SHEET 2 D 4 THR L 129 PHE L 139 -1 O VAL L 133 N PHE L 118 SHEET 3 D 4 TYR L 173 SER L 182 -1 O LEU L 179 N VAL L 132 SHEET 4 D 4 SER L 159 VAL L 163 -1 N GLN L 160 O THR L 178 SHEET 1 E 4 ALA L 153 LEU L 154 0 SHEET 2 E 4 ALA L 144 VAL L 150 -1 N VAL L 150 O ALA L 153 SHEET 3 E 4 VAL L 191 HIS L 198 -1 O GLU L 195 N GLN L 147 SHEET 4 E 4 VAL L 205 ASN L 210 -1 O VAL L 205 N VAL L 196 SHEET 1 F 4 GLN H 3 GLN H 6 0 SHEET 2 F 4 VAL H 18 SER H 25 -1 O LYS H 23 N VAL H 5 SHEET 3 F 4 THR H 77 LEU H 82 -1 O ALA H 78 N CYS H 22 SHEET 4 F 4 ILE H 67 ASP H 72 -1 N ASP H 72 O THR H 77 SHEET 1 G 6 GLU H 10 LYS H 12 0 SHEET 2 G 6 THR H 107 VAL H 111 1 O THR H 110 N GLU H 10 SHEET 3 G 6 ALA H 88 THR H 97 -1 N TYR H 90 O THR H 107 SHEET 4 G 6 LEU H 34 GLN H 39 -1 N VAL H 37 O TYR H 91 SHEET 5 G 6 LEU H 45 ILE H 52 -1 O MET H 48 N TRP H 36 SHEET 6 G 6 ILE H 56 TYR H 59 -1 O ASN H 58 N GLY H 50 SHEET 1 H 4 GLU H 10 LYS H 12 0 SHEET 2 H 4 THR H 107 VAL H 111 1 O THR H 110 N GLU H 10 SHEET 3 H 4 ALA H 88 THR H 97 -1 N TYR H 90 O THR H 107 SHEET 4 H 4 PRO H 100F TRP H 103 -1 O HIS H 102 N ARG H 94 SHEET 1 I 4 SER H 120 LEU H 124 0 SHEET 2 I 4 THR H 137 TYR H 147 -1 O LEU H 143 N PHE H 122 SHEET 3 I 4 TYR H 185 PRO H 194 -1 O TYR H 185 N TYR H 147 SHEET 4 I 4 VAL H 171 THR H 173 -1 N HIS H 172 O VAL H 190 SHEET 1 J 4 SER H 120 LEU H 124 0 SHEET 2 J 4 THR H 137 TYR H 147 -1 O LEU H 143 N PHE H 122 SHEET 3 J 4 TYR H 185 PRO H 194 -1 O TYR H 185 N TYR H 147 SHEET 4 J 4 VAL H 177 LEU H 178 -1 N VAL H 177 O SER H 186 SHEET 1 K 3 THR H 153 TRP H 157 0 SHEET 2 K 3 TYR H 206 HIS H 212 -1 O ASN H 209 N SER H 156 SHEET 3 K 3 THR H 217 VAL H 225 -1 O VAL H 219 N VAL H 210 SSBOND 1 CYS L 23 CYS L 88 1555 1555 2.06 SSBOND 2 CYS L 134 CYS L 194 1555 1555 2.03 SSBOND 3 CYS H 22 CYS H 92 1555 1555 2.04 SSBOND 4 CYS H 142 CYS H 208 1555 1555 2.03 CISPEP 1 SER L 7 PRO L 8 0 0.02 CISPEP 2 TYR L 140 PRO L 141 0 0.14 CISPEP 3 PHE H 148 PRO H 149 0 -0.26 CISPEP 4 GLU H 150 PRO H 151 0 0.12 SITE 1 AC1 9 PHE H 174 PRO H 175 VAL H 177 SER H 186 SITE 2 AC1 9 LEU H 187 SER H 188 SER L 162 SER L 176 SITE 3 AC1 9 THR L 178 CRYST1 157.940 44.658 85.264 90.00 113.09 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.006332 0.000000 0.002699 0.00000 SCALE2 0.000000 0.022392 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012750 0.00000